| RS1057518293 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1057518295 |
RERE
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without anomalies of the brain, eye |
| RS1057518297 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1057518298 |
SLC13A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 25 |
| RS1057518299 |
SLC13A5
|
Health Risk |
Pathogenic |
— |
| RS1057518301 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Timothy syndrome, Long QT syndrome |
| RS1057518303 |
HCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 8, Cardiovascular phenotype |
| RS1057518309 |
DSP
|
Health Risk |
Pathogenic |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS1057518312 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1057518318 |
ARID1B
|
Health Risk |
Likely pathogenic |
— |
| RS1057518321 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1057518322 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1057518325 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1057518326 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1057518327 |
SLC26A2
|
Health Risk |
Likely pathogenic |
— |
| RS1057518331 |
STXBP1
|
Health Risk |
Pathogenic |
— |
| RS1057518332 |
TBCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypotonia, infantile |
| RS1057518333 |
SIM1
|
Health Risk |
Likely pathogenic |
Brachydactyly, Brachydactyly |
| RS1057518336 |
LZTR1
|
Health Risk |
Likely pathogenic |
— |
| RS1057518337 |
PHIP
|
Health Risk |
Likely pathogenic |
— |
| RS1057518339 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1057518341 |
ASNS
|
Health Risk |
Likely pathogenic |
— |
| RS1057518344 |
SGCE
|
Health Risk |
Pathogenic |
— |
| RS1057518345 |
ADNP
|
Health Risk |
Pathogenic |
Inborn genetic diseases, ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder |
| RS1057518348 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1057518352 |
SYNGAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS1057518353 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Arthrogryposis multiplex congenita 6 |
| RS1057518354 |
BPTF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies |
| RS1057518356 |
SCN8A
|
Health Risk |
Likely pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1057518360 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1057518362 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1057518367 |
RASA1
|
Health Risk |
Likely pathogenic |
— |
| RS1057518368 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS1057518370 |
ATP7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Menkes kinky-hair syndrome, Cutis laxa |
| RS1057518371 |
ZEB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mowat-Wilson syndrome, Inborn genetic diseases |
| RS1057518372 |
COL3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1057518373 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS1057518377 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1057518379 |
NEK9
|
Health Risk |
Likely pathogenic |
— |
| RS1057518385 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1057518387 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS1057518388 |
MFSD8
|
Health Risk |
Likely pathogenic |
Late-infantile neuronal ceroid lipofuscinosis, Late-infantile neuronal ceroid lipofuscinosis |
| RS1057518389 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS1057518390 |
GALC
|
Health Risk |
Pathogenic |
— |
| RS1057518391 |
MMP13
|
Health Risk |
Likely pathogenic |
— |
| RS1057518398 |
MYH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Myopathy, proximal |
| RS1057518399 |
TP63
|
Health Risk |
Likely pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS1057518400 |
PTCH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1057518408 |
ACADM
|
Health Risk |
Likely pathogenic |
— |
| RS1057518410 |
SETD2
|
Health Risk |
Pathogenic |
Neoplasm, Neoplasm |
| RS1057518411 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1057518412 |
TUBB
|
Health Risk |
Likely pathogenic |
— |
| RS1057518414 |
SMARCA2
|
Health Risk |
Pathogenic |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS1057518416 |
TAFAZZIN
|
Health Risk |
Likely pathogenic |
3-Methylglutaconic aciduria type 2, Thyroid cancer |
| RS1057518419 |
SOX9
|
Health Risk |
Likely pathogenic |
— |
| RS1057518420 |
CACNA2D2
|
Health Risk |
Pathogenic |
— |
| RS1057518422 |
TAB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Atrial septal defect, ostium secundum type |
| RS1057518424 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS1057518425 |
PTEN
|
Health Risk |
Likely pathogenic |
PTEN hamartoma tumor syndrome, Glioma susceptibility 2 |
| RS1057518437 |
TAB2
|
Health Risk |
Pathogenic |
— |
| RS1057518440 |
GNAO1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 17 |
| RS1057518444 |
FBN1
|
Health Risk |
Likely pathogenic |
— |
| RS1057518448 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS1057518457 |
ATP2A2
|
Health Risk |
Likely pathogenic |
— |
| RS1057518458 |
ASXL1
|
Health Risk |
Pathogenic |
— |
| RS1057518470 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1057518472 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1057518474 |
DYRK1A
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1057518475 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1057518476 |
NONO
|
Health Risk |
Pathogenic |
— |
| RS1057518477 |
TSPAN12
|
Health Risk |
Pathogenic |
Exudative vitreoretinopathy 5, Exudative vitreoretinopathy 5 |
| RS1057518479 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontometaphyseal dysplasia, Melnick-Needles syndrome |
| RS1057518487 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1057518489 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057518492 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1057518493 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1057518496 |
SATB2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1057518498 |
CREBBP
|
Health Risk |
Likely pathogenic |
— |
| RS1057518500 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057518506 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1057518508 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS1057518511 |
BAG3
|
Health Risk |
Pathogenic/Likely pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS1057518513 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1057518514 |
ATP1A2
|
Health Risk |
Pathogenic |
Familial hemiplegic migraine, Familial hemiplegic migraine |
| RS1057518520 |
GRIN2B
|
Health Risk |
Likely pathogenic |
— |
| RS1057518526 |
OFD1
|
Health Risk |
Pathogenic |
— |
| RS1057518529 |
ALDH7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS1057518535 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS1057518541 |
ALDH18A1
|
Health Risk |
Likely pathogenic |
— |
| RS1057518543 |
KAT6A
|
Health Risk |
Pathogenic |
— |
| RS1057518544 |
JAK3
|
Health Risk |
Conflicting classifications of pathogenicity |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS1057518554 |
FBN1
|
Health Risk |
Pathogenic |
— |
| RS1057518555 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS1057518558 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS1057518560 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1057518567 |
MBD5
|
Health Risk |
Likely pathogenic |
— |
| RS1057518568 |
MECP2
|
Health Risk |
Likely pathogenic |
— |
| RS1057518571 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1057518572 |
MEN1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS1057518574 |
CYP19A1
|
Health Risk |
Likely pathogenic |
— |